Investment timeline
See how our science and investment timelines align to bring our treatment to patients.
-
2024
Pre-seed
Founded with support from DSV and CFF. Technology proof-of-concept experiments.
-
2025
Pre-seed extension
Deep dive analysis of components to identify final architecture.
-
2026
Seed
Efficacy, safety and translation to pre-clinical studies.
-
2027
Series A
First time in human.
-
Join
Our
Mission
